May 29, 2015 /

CAT-1004 (Catabasis) Clinical Trial Webinar (May 2015)

by: Parent Project Muscular Dystrophy

CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015]

On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy.

11 years ago

Research & Clinical Trial Webinars,

You may also like

Gene Therapy for Duchenne - PART 2: Nationwide Children's Hospital (September 2017)

Gene Therapy for Duchenne – PART 2: Nationwide Children’s Hospital (September 2017)

8 years ago

Research & Clinical Trial Webinars,

Gene Therapy for Duchenne (August 2017)

Gene Therapy for Duchenne (August 2017)

8 years ago

Research & Clinical Trial Webinars,

Nationwide Children’s Hospital Carrier Study (May 2017)

Nationwide Children’s Hospital Carrier Study (May 2017)

9 years ago

Research & Clinical Trial Webinars,

Results from Phase I/II HOPE Clinical Trial of CAP-1002 (April 2017)

Results from Phase I/II HOPE Clinical Trial of CAP-1002 (April 2017)

9 years ago

Research & Clinical Trial Webinars,

Givinostat in Duchenne (April 2017)

Givinostat in Duchenne (April 2017)

9 years ago

Research & Clinical Trial Webinars,

Akashi Provides Update on HT-100 (March 2017)

Akashi Provides Update on HT-100 (March 2017)

9 years ago

Research & Clinical Trial Webinars,

Idebenone Clinical Trials in Duchenne (March 2017)

Idebenone Clinical Trials in Duchenne (March 2017)

9 years ago

Research & Clinical Trial Webinars,

NS Pharma's Exon 53 Skipping Program: Trial Recruitment & Update (February 2017)

NS Pharma’s Exon 53 Skipping Program: Trial Recruitment & Update (February 2017)

9 years ago

Research & Clinical Trial Webinars,

«1…19 202122 23…28 »

Page 21 of 28

Join Our Mailing List